VANDA PHARMACEUTICALS INC. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
VANDA PHARMACEUTICALS INC. (VNDA) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $599.00 thousand as of 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2018-11-07
- 2018-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $599.00K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $1.20M.
- 2017-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $585.00K.
- 2017-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $1.10M.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2018-09-30 | $599.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $1.20M 10-Q · filed 2018-08-02 |
| 2017-09-30 | $585.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.10M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $1.51M 10-Q · filed 2017-05-03 |
| 2016-09-30 | $445.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $917.00K 10-Q · filed 2016-07-28 |
| 2016-03-31 | $1.13M 10-Q · filed 2016-05-05 |
| 2015-09-30 | $368.00K 10-Q · filed 2015-11-04 |
| 2015-06-30 | $736.00K 10-Q · filed 2015-07-31 |
| 2015-03-31 | $1.13M 10-Q · filed 2015-05-07 |
| 2014-09-30 | $323.00K 10-Q · filed 2014-10-27 |
| 2014-06-30 | $587.00K 10-Q · filed 2014-08-08 |
| 2014-03-31 | $851.00K 10-Q · filed 2014-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |